NASDAQ · Biotechnology

VRDN (VRDN) Stock

$19.48 -1.14% NASDAQ: VRDN Healthcare

Valuation

MetricValue
Price$19.48
Market Cap$1.75B
P/E Ratio-4.81
P/B Ratio1.88
P/S Ratio19.26
EPS (TTM)$-3.32
52-Week High$34.29
52-Week Low$13.18
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-47.51%
ROA-38.15%
ROCE-50.28%
Gross Margin-511.27%
Operating Margin-511.27%
Net Margin-5.08%
Debt/Equity0.08
Current Ratio12.59

Annual Financials (USD)

Metric20212022202320242025
Revenue$3.0M$2.0M$0$0$71.0M
Operating Profit$-80.0M$-134.0M$-254.0M$-299.0M$-363.0M
Net Profit$-79.0M$-130.0M$-238.0M$-270.0M$-343.0M
EPS$-6.66$-3.91$-5.31$-3.98$-3.32
Op Margin-2690.8%-7579.2%-81035.0%-99018.2%-512.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$204.0M$435.0M$490.0M$742.0M$899.0M
Total Liabilities$16.0M$40.0M$48.0M$71.0M$177.0M
Cash$42.0M$156.0M$103.0M$100.0M$212.0M
Borrowings$1.0M$5.0M$21.0M$21.0M$51.0M

Latest News

Lumvoa’s Unique Profile Leads to Optimism Around Viridian Therapeutics (VRDN) Insider Monkey · Jul 15, 2026 Viridian Therapeutics (VRDN) Rebounds Sharply, Is The Valuation Still Too Rich? Simply Wall St. · Jul 15, 2026 Viridian Therapeutics (VRDN) Stock Still Looks Above Fair Value Today Simply Wall St. · Jul 15, 2026 “Stay Invested”: Wells Fargo Picks 2 Stocks to Buy as It Stays Bullish on the Market TipRanks · Jul 14, 2026 Wedbush Sees Commercial Edge for Viridian (VRDN) After FDA Milestone Insider Monkey · Jul 6, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-55.0M$-94.0M$-184.0M$-232.0M$-276.0M
Investing Cash Flow$-75.0M$-116.0M$-95.0M$-229.0M$-38.0M
Financing Cash Flow$-6.0M$-19.0M$9.0M$-21.0M$50.0M
Net Cash Flow$-4.0M$113.0M$-53.0M$-3.0M$113.0M
Free Cash Flow$-55.0M$-95.0M$-185.0M$-233.0M$-277.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-22.24%
Quick Ratio15.15
Interest Coverage-72.60
Return 1Y7.35%
Return 3Y-4.22%
Return 5Y12.03%

Ownership

Insiders Held0.14%
Institutions Held111.89%
Institutions Float Held112.05%
Institutional HolderSharesReport Date
FMR, LLC15,379,3772026-03-31
Blackrock Inc.7,831,4752026-03-31
Bellevue Group AG6,726,1442026-03-31
State Street Corporation4,672,8852026-03-31
Vanguard Capital Management LLC4,167,2012026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About VRDN

VRDN is led by CEO Stephen F. Mahoney, employs 143 people, headquartered in US, publicly traded since 2014.

VRDN stock trades at $19.48 with a market capitalization of $1.75B. The stock is valued at a price-to-earnings (P/E) ratio of -4.81, price-to-book of 1.88, price-to-sales of 19.26. Over the past 52 weeks the stock has ranged between $13.18 and $34.29, and currently trades 43.2% below its 52-week high.

On profitability, VRDN generates a return on equity (ROE) of -47.51%, return on capital employed of -50.28%, an operating margin of -511.27%, a net profit margin of -5.08%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides